Clinical trial Recruiting at 1 site Interventional Ages 18 and up

eCardiacRehab: a home-based, patient-centered cardiac rehab program

Official title: eCardiacRehab - a Randomized Controlled Trial on a Hybrid Home-Based Patient-Centered eHealth Programme With Tailored Solutions

Run by Haukeland University Hospital · NCT07590635 · Data updated 2026-11-12

This trial tests a hybrid home-based cardiac rehabilitation program to see if it reduces cardiovascular deaths and ED visits while improving quality of life for adults with CAD after PCI, compared with usual care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorHaukeland University Hospital
Academic / other
Locations1 site (Bergen)
StatusRecruiting
StartedMay 21, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2037
Registry record updatedJune 23, 2026
Trial IDNCT07590635 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with CAD after PCI, living at home, internet access, and able to participate in a home-based program, who speak Norwegian or Scandinavian languages.

Probably not a fit

Patients unable to participate due to cognitive impairment, unstable medical condition, incomplete revascularization, or barriers to protocol adherence may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized PROBE trial evaluates a hybrid, home-based cardiac rehabilitation program designed to be accessible to patients who may not attend traditional center-based rehab. The study compares eCardiacRehab to usual care in adults with coronary artery disease treated with PCI, focusing on cardiovascular outcomes, ED utilization, and quality of life. Secondary aims explore effects across subgroups (age, sex, hypertension, multimorbidity, mental health), medication adherence, risk factor burden, and non-inferiority to in-person rehabilitation when applicable. The trial also includes health economic analyses to assess cost-utility and overall value. Recruitment is conducted in Norway with internet-enabled participation and language considerations for Norwegian/Scandinavian speakers.

Why it matters

Potential benefit: If successful, patients could gain improved quality of life and reduced risk of CV death and emergency care, with greater access to rehabilitation regardless of location.

How similar studies have gone: Previous studies exploring home-based or hybrid cardiac rehabilitation have shown varying degrees of benefit; this trial tests a comprehensive, patient-centered approach in a real-world setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult Norwegian (or Scandinavian) speaking patients (≥ 18 years) who have a Norwegian national identification number
* With coronary artery disease after percutaneous coronary intervention
* Living at home
* Have internet available
* Provide signed informed consent

Exclusion Criteria:

* Patients with cognitive impairment that may interfere with the ability to comply with the study protocol
* Severe aortic stenosis
* Severe arrhythmias
* Expected lifetime less than one year as determined by study personnel
* Otherwise clinically unstable
* Not fully revascularized
* Awaits percutaneous coronary intervention or coronary artery bypass graft surgery
* Inability to comply with the study protocol due to any physical disability, somatic disease, or mental problems as determined by study personnel

Where it's running

  • Haukeland University Hospital
    Bergen, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.